NCT06677970View on ClinicalTrials.gov

Outcome in Patients Treated With Endovascular Thrombectomy - optIMAL Blood Pressure Control 2 (OPTIMAL-BP 2)

PHASE3RecruitingINTERVENTIONAL
Enrollment

176

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

December 30, 2028

Study Completion Date

December 30, 2028

Conditions
Acute Ischemic Stroke
Interventions
DRUG

BP lowering drugs (nicardipine, labetalol, urapidil)

After successful reperfusion, appropriate antihypertension medication is administered to control systolic blood pressure \<180 mmHg.

DRUG

BP raising drug (phenylephrine) or BP lowering drugs (nicardipine, labetalol, urapidil)

After successful reperfusion, appropriate BP raising (20% increase in SBP, maximum of 180 from baseline SBP) are administered.

Trial Locations (1)

120-752

RECRUITING

Department of Neurology, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER